LVP software of the Ivenix Infusion System (IIS); Product Code LVP-SW-0005. Recall
LVP software of the Ivenix Infusion System (IIS); Product Code LVP-SW-0005.
FDA recall Class I
Ongoing
FDA lists this Class I recall for LVP software of the Ivenix Infusion System (IIS); Product Code LVP-SW-0005.. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-2223-2026
- Recall classification
- Class I
- Enforcement status
- Ongoing
- Initiation date
- May 6, 2026
- FDA report date
- Jun 10, 2026
- Quantity in commerce
- 32 systems
- Distribution
- See key details
- FDA cause
- Software design (manufacturing process)
What is being recalled?
LVP software of the Ivenix Infusion System (IIS); Product Code LVP-SW-0005.
Affected model & UDI checker
Search the exact identifiers published for Z-2223-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| Not specified | LVP software of the Ivenix Infusion System (IIS); Product Code LVP-SW-0005. | Check source notice | 00811505030122 |
FDA code information
Product Code LVP-SW-0005. UDI-DI: 00811505030122. Software Version 5.10.2
Why was this product recalled?
Potential software anomaly that can cause the pump to report a false battery-health value (typically 69%) and trigger a battery-depletion alarm that will shut down the pump unless it is reconnected to AC mains power.
These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.
What actions did Fresenius Kabi USA, LLC take?
Consignees were notified on about 05/06/2026 via letter. Consignees were informed of the issue, risk associated, and instructed to keep the Ivenix pump plugged in at all times rather than rely on battery and if a "Battery Extremely Low" alarm occurs while on battery, immediately connect the pump to AC. For any transport of a patient on an affected pump, have a plan for AC access. For patients receiving critical or short half-life infusion therapies, ensure an RN accompanies the patient during transport. Consignees were also instructed to notify other users if applicable, notify customers if affected units were transferred or distributed, and post the provided Safety Tip Sheet, Battery Health Software Anomaly in the Ivenix Large Volume Pump (LVP) notice alongside this letter in all areas where affected pumps are stored and used. consignees were asked to complete and return the provided Customer Reply Form.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-2223-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 21, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 21, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology